A report from London in today’s Daily Telegraph suggests that:
The Government is urging pharmaceutical companies to lower their initial prices for new drugs, with the promise that the [National Health Service] will pay more for them if evidence proves greater effectiveness.
Filed under: Business strategy, Health and drug costs, health economics | Tagged: pharmaceuticals, pricing, UK | Comments Off

